{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:15:38Z","timestamp":1789038938193,"version":"build-2803163510"},"reference-count":20,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.1248\/bpb.b25-00515","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:06:06Z","timestamp":1763589966000},"page":"1803-1809","source":"Crossref","is-referenced-by-count":2,"title":["A Multicenter Retrospective Observational Study on Drug\u2013Drug Interactions between Opioid Analgesics and Immune Checkpoint Inhibitors in Cancer Patients"],"prefix":"10.1248","volume":"48","author":[{"given":"Akime","family":"Miyasato","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Tokyo Medical University Hospital, 6\u20137\u20131 Nishishinjuku, Shinjuku-ku, Tokyo 160\u20130023, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791\u20130295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyui","family":"Funato","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gifu University Hospital, 1\u20131 Yanagido, Gifu 501\u20131194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shizuoka General Hospital, 4\u201327\u20131 Kita Ando, Aoi-ku, Shizuoka 420\u20138527, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Ouchi","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmaceutics and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 1\u201315\u20131 Fukumuro, Miyagino-ku, Sendai 983\u20138536, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Awaji","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, 1\u20137\u20131 Nagayama, Tama, Tokyo 206\u20138512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University, 7\u20137\u20131 Narashinodai, Funabashi, Chiba 274\u20138555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Kokubun","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology, Department of Clinical Pharmacy, Shonan University of Medical Sciences, 16\u201310 Kamishinano, Totsuka-ku, Yokohama 244\u20130806, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) B\u00f6rner C, Warnick B, Smida M, Hartig R, Lindquist JA, Schraven B, H\u00f6llt V, Kraus J. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling. <i>J. Immunol.<\/i>, <b>183<\/b>, 882\u2013889 (2009).","DOI":"10.4049\/jimmunol.0802763"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Cornwell WD, Lewis MG, Fan X, Rappaport J, Rogers TJ. Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques. <i>J. Neuroimmunol.<\/i>, <b>265<\/b>, 43\u201350 (2013).","DOI":"10.1016\/j.jneuroim.2013.09.013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ju M, Gao Z, Liu X, Zhou H, Wang R, Zheng C, Dong D, Zhu Z, Li K. The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. <i>J. Cancer Res. Clin. Oncol.<\/i>, <b>149<\/b>, 2699\u20132708 (2023).","DOI":"10.1007\/s00432-022-04513-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Chen G, Kim YH, Li H, Luo H, Liu DL, Zhang ZJ, Lay M, Chang W, Zhang YQ, Ji RR. PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity <i>via<\/i> PD-1. <i>Nat. Neurosci.<\/i>, <b>20<\/b>, 917\u2013926 (2017).","DOI":"10.1038\/nn.4571"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wang Z, Jiang C, He Q, Matsuda M, Han Q, Wang K, Bang S, Ding H, Ko MC, Ji RR. Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. <i>Sci. Transl. Med.<\/i>, <b>12<\/b>, eaaw6471 (2020).","DOI":"10.1126\/scitranslmed.aaw6471"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sumimoto T, Tanaka R, Shiraiwa K, Tatsuta R, Itoh H. Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: a case report. <i>J. Clin. Pharm. Ther.<\/i>, <b>47<\/b>, 552\u2013555 (2022).","DOI":"10.1111\/jcpt.13541"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sumimoto T, Tanaka R, Murakami Y, Tatsuta R, Itoh H. Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: a retrospective propensity score analysis. <i>Br. J. Clin. Pharmacol.<\/i>, <b>91<\/b>, 1409\u20131418 (2025).","DOI":"10.1111\/bcp.16377"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iglesias-Santamar\u00eda A. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer. <i>Clin. Transl. Oncol.<\/i>, <b>22<\/b>, 1481\u20131490 (2020).","DOI":"10.1007\/s12094-019-02282-w"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Taniguchi Y, Tamiya A, Matsuda Y, Adachi Y, Enomoto T, Azuma K, Kouno S, Tokoro A, Atagi S. Opioids impair nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer. <i>BMJ Support. Palliat. Care<\/i>, <b>13<\/b> (e1), e185\u2013e189 (2023).","DOI":"10.1136\/bmjspcare-2020-002480"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Botticelli A, Cirillo A, Pomati G, Cerbelli B, Scagnoli S, Roberto M, Gelibter A, Mammone G, Calandrella ML, Cerbelli E, Di Pietro FR, De Galitiis F, Lanzetta G, Cortesi E, Mezi S, Marchetti P. The role of opioids in cancer response to immunotherapy. <i>J. Transl. Med.<\/i>, <b>19<\/b>, 119 (2021).","DOI":"10.1186\/s12967-021-02784-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kostine M, Mauric E, Tison A, <i>et al<\/i>. FHU ACRONIM. Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events. <i>Eur. J. Cancer<\/i>, <b>157<\/b>, 474\u2013484 (2021).","DOI":"10.1016\/j.ejca.2021.08.036"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miura K, Sano Y, Niho S, Kawasumi K, Mochizuki N, Yoh K, Matsumoto S, Zenke Y, Ikeda T, Nosaki K, Kirita K, Udagawa H, Goto K, Kawasaki T, Hanada K. Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a retrospective study. <i>Thorac. Cancer<\/i>, <b>12<\/b>, 1983\u20131994 (2021).","DOI":"10.1111\/1759-7714.14001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Verschueren MV, van der Welle CMC, Tonn M, Schramel FMNH, Peters BJM, van de Garde EMW. The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC. <i>Sci. Rep.<\/i>, <b>11<\/b>, 23331 (2021).","DOI":"10.1038\/s41598-021-02598-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yu X, Zhao L, Song B. Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population. <i>BMC Pulm. Med.<\/i>, <b>22<\/b>, 431 (2022).","DOI":"10.1186\/s12890-022-02210-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. <i>N. Engl. J. Med.<\/i>, <b>363<\/b>, 733\u2013742 (2010).","DOI":"10.1056\/NEJMoa1000678"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Page GG, Ben-Eliyahu S. The immune-suppressive nature of pain. <i>Semin. Oncol. Nurs.<\/i>, <b>13<\/b>, 10\u201315 (1997).","DOI":"10.1016\/S0749-2081(97)80044-7"},{"key":"17","unstructured":"17) Maneckjee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. <i>Cell Growth Differ.<\/i>, <b>5<\/b>, 1033\u20131040 (1994)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Zaj\u0105czkowska R, Leppert W, Mika J, Kocot-K\u0119pska M, Woro\u0144 J, Wrzosek A, Wordliczek J. Perioperative immunosuppression and risk of cancer progression: the impact of opioids on pain management. <i>Pain Res. Manag.<\/i>, <b>2018<\/b>, 9293704 (2018).","DOI":"10.1155\/2018\/9293704"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sacerdote P, Manfredi B, Mantegazza P, Panerai AE. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. <i>Br. J. Pharmacol.<\/i>, <b>121<\/b>, 834\u2013840 (1997).","DOI":"10.1038\/sj.bjp.0701138"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Franchi S, Panerai AE, Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. <i>Brain Behav. Immun.<\/i>, <b>21<\/b>, 767\u2013774 (2007).","DOI":"10.1016\/j.bbi.2007.01.001"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00515\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T03:24:09Z","timestamp":1763781849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00515\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00515","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"b25-00515"}}